HT1080/DR4: A P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase ii

Journal of the National Cancer Institute

Volumn 82, Issue 19, 1990, Pages 1553-1561

  Zwelling, Leonard A ^a   Slovak, Marilyn L ^b   Doroshow, James H ^b   Hinds, Michael ^a   Chan, Diana ^a   Parker, Elizabeth ^a   Mayes, Janice ^a   Sie, Kiem Lan ^a   Meltzer, Paul S ^c   Trent, Jeffrey M ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 IMINODAUNORUBICIN; AMSACRINE; DNA TOPOISOMERASE; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; NSC 254681; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; DRUG RESISTANCE; FIBROSARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

AMSACRINE; CATALASE; CELL LINE; CELL NUCLEUS; DNA PROBES; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG RESISTANCE; ETOPOSIDE; FIBROSARCOMA; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMAN; KINETICS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; SUPEROXIDE DISMUTASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025118359     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/82.19.1553     Document Type: Article

References (62)

1. Endicott JA, Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137-171, 1989
2. Sullivan DM, Glisson BS, Hodges PK, et al: Proliferation dependence of topoisomerase II mediated drug action Biochemistry 25:2248-2256, 1986
3. Sullivan DM, Latham MD, Ross WE: Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. Cancer Res 47:3973-3979, 1987
4. Zwelling LA, Estey E, Silberman L, ET AL: Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts. Cancer Res 47:251-257, 1987
5. Markovits J, Pommier Y, Kerrigan D, ET AL: Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and LI 210 leukemia cells. Cancer Res 47:2050-2055, 1987
6. Hsiang Y-H, Wu H-Y, Liu LF: Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res 48:3230-3235, 1988
7. Ross WE, Sullivan DM, Chow K-C: Altered function of DNA topoisomerases as a basis for antineoplastic drug action. In Important Advances in Oncology (DeVita VT Jr, Hellman S, Rosenberg SA, eds). New York: Lippincott, 1988, pp 65-81
8. Liu LF: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-375, 1989
9. Zwelung LA: Topoisomerase II as a target of antileukemia drugs: A review of controversial areas. Hematol Pathol 3:101-112, 1989
10. Zwelung LA, Hinds M, Chan D, et al: Characterization of an amsacrineresistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. J Biol Chem 264:16411-16420, 1989
11. Sullivan DM, Latham MD, Rowe TC, et al Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line. Biochemistry 28:5680-5687, 1989
12. Danks MK, Schmidt CA, Cirtain MC, et al: Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry 27:8861-8869, 1988
13. Drake FH, Zimmerman JP, Mccabe FL, et al: Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme. J Biol Chem 262:16739-16747, 1987
14. Tewey KM, Rowe TC, Yang L, et al: Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226:466-468, 1984
15. Gottesman MM, Pastan I: The multidrug transporter, a double-edged sword. J Biol Chem 263:12163-12166, 1988
16. Slovak ML, Hoeltge GA, Trent JM: Cytogenetic alterations associated with the acquisition of doxorubicin resistance: Possible significance of chromosome 7 alterations. Cancer Res 47:6646-6652, 1987
17. Slovak ML, Hoeltge GA, Dalton WS, et al: Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res 48:2793-2797, 1988
18. Zwelung LA, Michaels S, Erickson LC, et al: Protein-associated deoxyribonucleic acid strand breaks in L1210cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfonm- anisidide and Adriamycin. Biochemistry 20:6553-6563, 1981
19. Bakic M, Chan D, Andersson BS, ET AL: Effect of 1-beta-D-arabinosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfonm- anisidide (AMSA) and etoposide in AMSA-sensitive and resistant human leukemia cells. Biochem Pharmacol 36:4067-4077, 1987
20. Zwelling LA, Kerrigan D, Michaels S: Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: Comparison with Adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide. Cancer Res 42:2687-2691, 1982
21. Zwelung LA, Michaels S, Kerrtgan D, et al: Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium. Biochem Pharmacol 31:3261-3267, 1982
22. Englund PT: The replication of kinetoplast DNA networks in Crithidia fasckulata.CeW 14:157-168, 1978
23. Liu LF, Rowe TC, Yang L, ET AL: Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem 258:15365-15370, 1983
24. Chu MY, Fischer GA: The incorporation of 3H-cytosine arabinoside and its effects on murine leukemic cells (L5178Y). Biochem Pharmacol 17:753-767, 1968
25. Zwelung LA, Kerrigan D, Michaels S, et al: Cooperative sequestration of m-AMSA in L1210cells. Biochem Pharmacol 31:3269-3277, 1982
26. Kohn KW, Ewig RAG, Erickson LC, et al: Measurement of strand breaks and cross-links by alkaline elution. In DNA Repair A Laboratory Manual of Research Techniques (Friedberg EC, Hanawalt PC, eds). New York: Marcel Dekker, 1981, pp 379-401
27. Pommier Y, Kerrtgan D, Schwartz R, et al: The formation and resealing of intercalator-induced DNA strand breaks in isolated LI210 cell nuclei. Biochem Biophys Res Commun 107:576-583, 1982
28. Minford J, Pommier Y, Frupski J, et al: Isolation of intercalatordependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Biochemistry 25:9-16, 1986
29. Beutler E, ED: Red Cell Metabolism: A Manual of Biochemical Methods. New York: Grune & Stratton, 1975, pp 66-69
30. Beutler E, ED: Red Cell Metabolism: A Manual of Biochemical Methods. New York: Grune & Stratton, 1975, pp 69-71
31. Beutler E, ED: Red Cell Metabolism: A Manual of Biochemical Methods. New York: Grune & Stratton, 1971, pp 66-68
32. Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139, 1974
33. Beutler E, ED: Red Cell Metabolism: A Manual of Biochemical Methods. New York: Grune & Stratton, 1975, pp 89-90
34. Doroshow JH, Locker GY, Myers CE: Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J Clin Invest 65:128-135, 1980
35. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
36. Armitage P: Statistical Methods in Medical Research. Oxford: Blackwell, 1971, pp 104-126
37. Winter EF, Yamamoto F, Almoguera C, et al: A method to detect and characterize point mutations in transcribed genes: Amplification and overexpression of the mutant c-Ki-ras allele inhuman tumor cells. Proc Natl Acad Sci USA 82:7575-7579, 1985
38. Chirgwin JM, Przybyla AE, Macdonald RJ, et al: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
39. Chen C-J, Chin JE, Ueda K, et al: Internal duplication and homology with bacterial transport proteins in the mdrl (P-glycoprotein) gene from multidrug- resistant human cells. Cell 47:381-389, 1986
40. Bakic M, Beran M, Andersson BS, ET AL: The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m- AMSA). Biochem Biophys Res Commun 134:638-645, 1986
41. Gusson B, Gupta R, Smallwood-Kentro S, et al: Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: Loss of drug-stimulated DNA cleavage activity. Cancer Res 46:1934-1938, 1986
42. Gusson B, Gupta R, Hodges P, et al: Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: Evidence for a common intracellular target. Cancer Res 46:1939-1942, 1986
43. Per SR, Mattern MR, Mirabelli CK, et al: Characterization of a subline of P388 leukemia resistant to amsacrine: Evidence of altered topoisomerase II function. Mol Pharmacol 32:17-25, 1987
44. Pommier Y, Schwartz RE, Zweujng LA, et al: Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res 46:611-616, 1986
45. Goldenberg GJ, Wang H, Blajrgw: Resistance to Adriamycin: Relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 46:2978-2983, 1986
46. Capranico G, Riva A, Tinelli S, et al: Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei. Cancer Res 47:3752-3756, 1987
47. Maniar N, Krishan A, Israel M, et al Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells. Biochem Pharmacol 37:1763-1772, 1988
48. Zuustra JG, DE Vries EGE, Mulder NH: Multifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47:1780-1784, 1987
49. Robson CN, Hoban PR, Harris AL, et al: Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines. Cancer Res 47:1560-1565, 1987
50. DA Vies SM, Robson CN, DA Vies SL, ET AL: Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J Biol Chem 263:17724-17729, 1988
51. Hsiang Y-H, Liu LF: Identification of mammalian topisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48:1722-1726, 1988
52. Hwang JL, Shyy SH, Chen AY, et al: Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide. Cancer Res 49:958-962,1989
53. Estey EH, Silberman L, Beran M, et al: The interaction between nuclear topoisomerase U activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-0- ethylidene-beta-D-glucopyranoside (VP-16) indicates the sensitivity of the cells to the drugs. Biochem Biophys Res Commun 144:787-793, 1987
54. Batist G, Tulpule A, Sinha BK, et al: Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261:15544-15549, 1986
55. Cowan KH, Batist G, Tulpule A, et al: Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci USA 83:9328-9332, 1986
56. Kalyanaraman B, Nemec J, Sinha BK: Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR study. Biochemistry 28:4839-4846, 1989
57. Chow K-C, Ross WE: Topoisomerase-specific drug sensitivity in relation to cell cycle progression. Mol Cell Biol 7:3119-3123, 1987
58. Sinha BK, Katki AG, Batist G, et al: Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem Pharmacol 36:793-796, 1987
59. Sinha BK, Katki AG, Batist G, et al: Differential formation of hydroxyl radicals by Adriamycin in sensitive and resistant MCF-7 human breast tumor cells: Implications for the mechanism of action. Biochemistry 26:3776- 3781,1987
60. Sinha BK, Haim N, Dusre L, et al: DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: Implications for the mechanism of action. Cancer Res 48:5096-5100,1988
61. Westendorf J, Marquardt H, Marquardt H: Structure-activity relationship of anthracycline-induced genotoxicity in vitro. Cancer Res 44:5599- 5604, 1984
62. Dalton WS, Durie BGM, Alberts DS, et al: Characterization of a new drug-resistant human myeloma cell line that expresses P-'glycoprotein. Cancer Res 46:5125-5130, 1986